Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Elf5 controls skin cell growth and development, making it a potential target for skin treatments.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Satoyoshi syndrome can occur without causing premature ovarian failure.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

A20 protein is crucial for normal skin and hair development.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

A 65-year-old woman has a growing bald spot on her scalp.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Finasteride, often used for hair loss, can potentially cause cataracts.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

Adding a second method to PROTACs could improve cancer treatment.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.